Reversal of methylcholanthrene-induced changes in mouse prostates in vitro by retinoic acid and its analogues.
The influence of vitamin A-related compounds on hyperplasia and metaplasia induced by methylcholanthrene was studied in mouse prostate glands in organ culture. Methylcholanthrene was found to cause extensive hyperplasia and squamous metaplasia of the prostatic epithelium which persisted after withdrawal of the carcinogen. The retinoids included retinoic acid and 6 of its structural analogues synthesized in an attempt to enhance the anticarcinogenic action and reduce the toxicity of the parent compound. These where the cyclopentenyl analogus 7699, A2-retinoic acid, 13-cis-alpha-retinoic acid and 3 aromatic analogues. Administration of the compounds following the carcinogen reduced the extent and incidence of hyperplasia significantly and with the exception of one compound reversed the squamous metaplasia. Two of the aromatic analogues, one with a terminal ethylamide group (1430), and the other with a terminal ethylester group (9369), proved to be the most potent inhibitors, followed by compound 7699 and (9369), proved to be the most potent inhibitors, followed by compound 7699 and retinoic acid. A2-retinoic acid and 13-cis-alpha-retinoic acid showed the lowest activity. The inhibition of hyperplasia appeared to be mediated via a reduction of DNA synthesis. It seemed unrelated to either the biological growth-promoting activity of the compounds or their surface-active properties. It is tentatively suggested that vitamin A and its analogues may act as hormones.
D000818:Animals; D004247:DNA / Q000096:biosynthesis; D006965:Hyperplasia / Q000139:chemically induced / Q000188:drug therapy; D066298:In Vitro Techniques; D008297:Male; D008679:Metaplasia / Q000139:chemically induced / Q000188:drug therapy; D008748:Methylcholanthrene; D051379:Mice; D008809:Mice, Inbred C3H; D008815:Mice, Inbred Strains; D011467:Prostate / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000139:chemically induced / Q000188:drug therapy*; D013936:Thymidine / Q000378:metabolism; D014212:Tretinoin / Q000031:analogs & derivatives / Q000627:therapeutic use*; D014801:Vitamin A / Q000031:analogs & derivatives*
D014801:Vitamin A; D008748:Methylcholanthrene; D014212:Tretinoin; D004247:DNA; D013936:Thymidine